41 results on '"Chapiro, J."'
Search Results
2. Abstract No. 171 ▪ FEATURED ABSTRACT The effect of anti-MMP-9 as a potential modulator of the post-cryoablation anti-tumor immune response in HCC
3. Abstract No. 533 Comparison of drug-eluting beads versus conventional transarterial chemoembolization: a cost-effectiveness analysis
4. 3:54 PM Abstract No. 342 Prostatic artery embolization with 100- to 300-μm microspheres to treat urinary retention caused by benign prostatic hyperplasia: medium-term outcomes with stratified obstructive and irritative symptom analysis
5. 4:12 PM Abstract No. 344 Stratified subscore analysis of International Prostate Symptom Score improvement after prostatic artery embolization with 100- to 300-μm microspheres for lower urinary tract symptoms
6. Abstract No. 495 Automated lesion classification in patients with hepatocellular carcinoma undergoing transarterial chemoembolization: a comparison of 3D image analysis algorithms
7. 03:09 PM Abstract No. 4 Prostatic artery embolization with 100- to 300-μm particles to treat lower urinary tract symptoms attributable to benign prostatic hyperplasia: a single-center analysis of 2-year outcomes
8. 03:09 PM Abstract No. 123 Identifying predictors of lower urinary tract symptom improvement after prostatic artery embolization
9. 03:54 PM Abstract No. 128 Accuracy of diagnostic ultrasound, CT, and MRI compared with volumetric cone-beam CT measurement in predicting hyperplastic prostate gland volume
10. 03:45 PM Abstract No. 117 Quantitative baseline imaging biomarkers for Yttrium-90 distribution on bremsstrahlung SPECT and tumor response prediction after radioembolization
11. Abstract No. 445 Predicting prostatic artery embolic particle deposition density based on gland volume and evaluating its effect on clinical outcomes for patients with lower urinary tract symptoms
12. 04:12 PM Abstract No. 11 Use of the Sniper® balloon-occlusion microcatheter in prostatic artery embolization: evaluation of clinical impacts on improvements in International Prostate Symptom score, Quality of Life score, and postvoid residual
13. Abstract No. 446 Prostatic artery embolization with 100μm-300μm particles to treat gross hematuria attributable to benign prostatic hyperplasia: A single-center analysis of 3-year outcomes
14. Abstract No. 447 Use of the Sniper® balloon-occlusion microcatheter in prostatic artery embolization: evaluation of technical impacts on fluoroscopy time, contrast use, protective collateral vessel coiling, and embolic particle deposition volume and density
15. Neoadjuvant biomarker research study of palbociclib combined with endocrine therapy in estrogen receptor positive/HER2 negative breast cancer: The phase II NeoRHEA trial
16. 4:21 PM Abstract No. 331 Quantitative analysis of Lipiodol washout rates in intrahepatic cholangiocarcinoma and hepatic metastasis from neuroendocrine tumors and colorectal cancer after chemoembolization
17. Abstract No. 517 Conventional vs. drug-eluting beads TACE for hepatocellular carcinoma: a propensity score–weighted comparison
18. Three-dimensional image analysis of hepatocellular carcinoma on dual-phase cone-beam CT acquired immediately before intra-arterial therapy: can it be used as an early predictor of tumor response?
19. Irinotecan-eluting LC Bead-M1 (DEBIRI-M1) for patients with liver metastases from colorectal cancer: a phase II single-center study
20. Identifying enhancement-based staging markers on baseline MR imaging in patients with colorectal cancer liver metastases undergoing loco-regional tumor therapy
21. Assessing tumor response to TACE in infiltrative HCC using an enhancement-based whole-liver approach
22. Which response criteria can predict early tumor response in CT image in hepatocellular carcinoma patients treated with TACE: RECIST, mRECIST, EASL or qEASL?
23. Improved liver lesion detectability using a split-bolus single-phase contrast-enhanced cone-beam CT (CBCT) before transarterial chemoembolization (TACE)
24. Does lesion enhancement pattern correlate between baseline MR and follow-up CT in patients with hepatocellular carcinoma (HCC) treated using conventional transarterial chemoembolization (cTACE)? A quantitative, multi-modality analysis
25. 3D quantification of viable tumor volume in patients with hepatocellular carcinoma predicts the hepato-pulmonary shunt fraction before Y90 radioembolization.
26. Evaluating Radiological Changes in Vestibular Schwannoma Patients Treated With Hypofractionated Stereotactic Radiation Therapy: A Potential Role for a Novel 3-D Quantitative Volumetric Assessment Tool
27. Selective hypoxia-activated intraarterial therapy in a rabbit liver tumor model
28. Radiologic-pathologic analysis of 3D quantitative tumor enhancement in HCC patients after TACE: influence of region-of-interest placement on measurements
29. A practical database management system to assist clinical research teams with data collecting, organization, and reporting
30. Treatment of uterine fibroids by uterine artery embolization: radiation exposure reduction on a new angiographic imaging platform
31. Multimodality 3D tumor segmentation in HCC patients treated with TACE
32. Can whole liver enhancement patterns predict survival in patients with extensive neuroendocrine liver metastases treated with transarterial chemoembolization?
33. Open trajectory cone-beam CT acquisition improves liver visualization during IR procedures
34. Quantitative semi-automatic 3D assessment of uterine fibroids after intra-arterial embolization - a feasibility study
35. Quantitative 3D volumetric assessment of tumor response after intra-arterial therapy of colorectal cancer metastases to the liver – a new surrogate marker for survival
36. Radio-pathological correlation of 3D-quantitative contrast-enhanced and functional MRI in HCC patients after TACE - do we see what we treat?
37. Targeting tumor glycolysis in pancreatic cancer - volumetric and functional tumor response assessment in an orthotopic mouse tumor model
38. Multi-modality visibility of radio-opaque microspheres during transarterial embolization in a rabbit model of liver cancer
39. Uveal melanoma metastatic to the liver: the role of quantitative and functional MR imaging in the assessment of early tumor response after TACE
40. Clinical application of a new technique with automatic bone removal program for cbct imaging in TACE planning
41. Overdosage of vinorelbine in a woman with metastatic non-small-cell lung carcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.